Grifols
Company Details
Linkedin ID:
grifols
Website:
Employees number:
13,839
Number of followers:
292,525
NAICS:
3254
Industry Type:
Homepage:
linktr.ee
IP Addresses:
151
Company ID:
GRI_7337752
Scan Status:
Completed
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
Grifols Vendor Cyber Rating & Cyber Score
linktr.eeGrifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.
Grifols A.I CyberSecurity Scoring
Grifols Risk Score (AI oriented)Between 750 and 799
Grifols
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Grifols Global Score (TPRM)XXXX
Grifols
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Grifols Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Grifols Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Grifols
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Grifols in 2026.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Grifols in 2026.
Incident Types Grifols vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Grifols in 2026.
Incident History — Grifols (X = Date, Y = Severity)
Grifols cyber incidents detection timeline including parent company and subsidiaries
Grifols Company Subsidiaries
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.
Loading...
Grifols Similar Companies
MANKIND PHARMA LTD
Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,
Novo Nordisk
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of scienc
Astellas Pharma
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneer
Sandoz
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health c
Zoetis
The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio an
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating wit
Cipla
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purp
PT Kalbe Farma, Tbk
Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the pa
.png)
Grifols CyberSecurity News
May 24, 2024 07:00 AM
Cencora data breach exposes patient data at top pharma firms
The Cencora breach affected some of the most prominent Big Pharma firms, including Novartis, Bayer, AbbVie, Regeneron, Genentech and Incyte.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Grifols CyberSecurity History Information
Official Website of Grifols
The official website of Grifols is https://linktr.ee/Grifols.
Grifols’s AI-Generated Cybersecurity Score
According to Rankiteo, Grifols’s AI-generated cybersecurity score is 773, reflecting their Fair security posture.
How many security badges does Grifols’ have ?
According to Rankiteo, Grifols currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Has Grifols been affected by any supply chain cyber incidents ?
According to Rankiteo, Grifols has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
Does Grifols have SOC 2 Type 1 certification ?
According to Rankiteo, Grifols is not certified under SOC 2 Type 1.
Does Grifols have SOC 2 Type 2 certification ?
According to Rankiteo, Grifols does not hold a SOC 2 Type 2 certification.
Does Grifols comply with GDPR ?
According to Rankiteo, Grifols is not listed as GDPR compliant.
Does Grifols have PCI DSS certification ?
According to Rankiteo, Grifols does not currently maintain PCI DSS compliance.
Does Grifols comply with HIPAA ?
According to Rankiteo, Grifols is not compliant with HIPAA regulations.
Does Grifols have ISO 27001 certification ?
According to Rankiteo,Grifols is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Grifols
Grifols operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Grifols
Grifols employs approximately 13,839 people worldwide.
Subsidiaries Owned by Grifols
Grifols presently has no subsidiaries across any sectors.
Grifols’s LinkedIn Followers
Grifols’s official LinkedIn profile has approximately 292,525 followers.
NAICS Classification of Grifols
Grifols is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Grifols’s Presence on Crunchbase
Yes, Grifols has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/grifols.
Grifols’s Presence on LinkedIn
Yes, Grifols maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/grifols.
Cybersecurity Incidents Involving Grifols
As of April 04, 2026, Rankiteo reports that Grifols has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Grifols has an estimated 5,608 peer or competitor companies worldwide.
Grifols CyberSecurity History Information
How many cyber incidents has Grifols faced ?
Total Incidents: According to Rankiteo, Grifols has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Grifols ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
nimiq/core-rs-albatross is a Rust implementation of the Nimiq Proof-of-Stake protocol based on the Albatross consensus algorithm. Prior to version 1.3.0, two peer-facing consensus request handlers assume that the history index is always available and call blockchain.history_store.history_index().unwrap() directly. That assumption is false by construction. HistoryStoreProxy::history_index() explicitly returns None for the valid HistoryStoreProxy::WithoutIndex state. when a full node is syncing or otherwise running without the history index, a remote peer can send RequestTransactionsProof or RequestTransactionReceiptsByAddress and trigger an Option::unwrap() panic on the request path. This issue has been patched in version 1.3.0.
Risk Information
cvss3
Base: 5.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
Description
PraisonAI is a multi-agent teams system. Prior to version 1.5.95, FileTools.download_file() in praisonaiagents validates the destination path but performs no validation on the url parameter, passing it directly to httpx.stream() with follow_redirects=True. An attacker who controls the URL can reach any host accessible from the server including cloud metadata services and internal network services. This issue has been patched in version 1.5.95.
Risk Information
cvss3
Base: 8.6
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
Description
PraisonAI is a multi-agent teams system. Prior to version 4.5.97, OAuthManager.validate_token() returns True for any token not found in its internal store, which is empty by default. Any HTTP request to the MCP server with an arbitrary Bearer token is treated as authenticated, granting full access to all registered tools and agent capabilities. This issue has been patched in version 4.5.97.
Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Description
PraisonAI is a multi-agent teams system. Prior to version 4.5.97, the PraisonAI Gateway server accepts WebSocket connections at /ws and serves agent topology at /info with no authentication. Any network client can connect, enumerate registered agents, and send arbitrary messages to agents and their tool sets. This issue has been patched in version 4.5.97.
Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Description
PraisonAI is a multi-agent teams system. Prior to version 4.5.90, MCPToolIndex.search_tools() compiles a caller-supplied string directly as a Python regular expression with no validation, sanitization, or timeout. A crafted regex causes catastrophic backtracking in the re engine, blocking the Python thread for hundreds of seconds and causing a complete service outage. This issue has been patched in version 4.5.90.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=grifols' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
